Associations of Insulin and Insulin-Like Growth Factors with Physical Performance in Old Age in the Boyd Orr and Caerphilly Studies

Objective Insulin and the insulin-like growth factor (IGF) system regulate growth and are involved in determining muscle mass, strength and body composition. We hypothesised that IGF-I and IGF-II are associated with improved, and insulin with worse, physical performance in old age. Methods Physical performance was measured using the get-up and go timed walk and flamingo balance test at 63–86 years. We examined prospective associations of insulin, IGF-I, IGF-II and IGFBP-3 with physical performance in the UK-based Caerphilly Prospective Study (CaPS; n = 739 men); and cross-sectional insulin, IGF-I, IGF-II, IGFBP-2 and IGFBP-3 in the Boyd Orr cohort (n = 182 men, 223 women). Results In confounder-adjusted models, there was some evidence in CaPS that a standard deviation (SD) increase in IGF-I was associated with 1.5% faster get-up and go test times (95% CI: −0.2%, 3.2%; p = 0.08), but little association with poor balance, 19 years later. Coefficients in Boyd Orr were in the same direction as CaPS, but consistent with chance. Higher levels of insulin were weakly associated with worse physical performance (CaPS and Boyd Orr combined: get-up and go time = 1.3% slower per SD log-transformed insulin; 95% CI: 0.0%, 2.7%; p = 0.07; OR poor balance 1.13; 95% CI; 0.98, 1.29; p = 0.08), although associations were attenuated after controlling for body mass index (BMI) and co-morbidities. In Boyd Orr, a one SD increase in IGFBP-2 was associated with 2.6% slower get-up and go times (95% CI: 0.4%, 4.8% slower; p = 0.02), but this was only seen when controlling for BMI and co-morbidities. There was no consistent evidence of associations of IGF-II, or IGFBP-3 with physical performance. Conclusions There was some evidence that high IGF-I and low insulin levels in middle-age were associated with improved physical performance in old age, but estimates were imprecise. Larger cohorts are required to confirm or refute the findings.

[1]  A. D. de Craen,et al.  Circulating levels of IGF1 are associated with muscle strength in middle-aged- and oldest-old women. , 2011, European journal of endocrinology.

[2]  D. Kuh,et al.  Objectively measured physical capability levels and mortality: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[3]  J. Gallacher,et al.  Socio-economic disadvantage from childhood to adulthood and locomotor function in old age: a lifecourse analysis of the Boyd Orr and Caerphilly prospective studies , 2010, Journal of Epidemiology & Community Health.

[4]  M. Carreira,et al.  The GH/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis. , 2010, The Journal of endocrinology.

[5]  H. Kuo,et al.  Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999-2002 , 2009, BMC geriatrics.

[6]  Ross J. Harris,et al.  Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysis , 2009, International journal of cancer.

[7]  S. Satterfield,et al.  Insulin Resistance Is Associated With Decreased Quadriceps Muscle Strength in Nondiabetic Adults Aged ≥70 Years , 2009, Diabetes Care.

[8]  L. V. van't Veer,et al.  No Effect of Red Clover–Derived Isoflavone Intervention on the Insulin-Like Growth Factor System in Women at Increased Risk of Colorectal Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[9]  L. Kuller,et al.  Total Insulinlike Growth Factor 1 and Insulinlike Growth Factor Binding Protein Levels, Functional Status, and Mortality in Older Adults , 2008, Journal of the American Geriatrics Society.

[10]  D. I. Givens,et al.  The Survival Advantage of Milk and Dairy Consumption: an Overview of Evidence from Cohort Studies of Vascular Diseases, Diabetes and Cancer , 2008, Journal of the American College of Nutrition.

[11]  L. Fried,et al.  Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study. , 2007, Archives of internal medicine.

[12]  M. Cesari,et al.  Body mass index, free insulin-like growth factor I, and physical function among older adults: results from the ilSIRENTE study. , 2006, American journal of physiology. Endocrinology and metabolism.

[13]  G. Davey Smith,et al.  Associations of adiposity from childhood into adulthood with insulin resistance and the insulin-like growth factor system: 65-year follow-up of the Boyd Orr Cohort. , 2006, The Journal of clinical endocrinology and metabolism.

[14]  G. Davey Smith,et al.  Associations of childhood and adulthood height and the components of height with insulin-like growth factor levels in adulthood: a 65-year follow-up of the Boyd Orr cohort. , 2006, The Journal of clinical endocrinology and metabolism.

[15]  G. Smith,et al.  Cohort profile: The Boyd Orr cohort--an historical cohort study based on the 65 year follow-up of the Carnegie Survey of Diet and Health (1937-39). , 2005, International journal of epidemiology.

[16]  A. Tamakoshi,et al.  Stability of Frozen Serum Levels of Insulin-like Growth Factor-I, Insulin-like Growth Factor-II, Insulin-like Growth Factor Binding Protein-3, Transforming Growth Factor β, Soluble Fas, and Superoxide Dismutase Activity for the JACC Study , 2005, Journal of epidemiology.

[17]  R. Hardy,et al.  Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  L. V. van't Veer,et al.  The insulin-like growth factor system in cancer prevention: potential of dietary intervention strategies. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  D. Grobbee,et al.  Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. , 2003, European journal of endocrinology.

[20]  D. Dunger,et al.  Low circulating IGF-II concentrations predict weight gain and obesity in humans. , 2003, Diabetes.

[21]  T. Peters,et al.  Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men , 2003, British Journal of Cancer.

[22]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[23]  E. Rimm,et al.  Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  R. Krajcik,et al.  Utility of insulin-like growth factor-1 as a biomarker in epidemiologic studies. , 2002, Clinical chemistry.

[25]  S. Hankinson,et al.  Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  E. Riboli,et al.  Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden) , 2002, Cancer Causes & Control.

[27]  D. Dunger,et al.  Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study , 2002, The Lancet.

[28]  L. Fried,et al.  Association of IGF-I levels with muscle strength and mobility in older women. , 2001, The Journal of clinical endocrinology and metabolism.

[29]  D. Dunger,et al.  Is there a medical need to explore the clinical use of insulin-like growth factor I? , 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[30]  T. Cole,et al.  Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data. , 2000, Statistics in medicine.

[31]  V. Hwa,et al.  The Insulin-like Growth Factor-binding Protein (igfbp) Superfamily* , 2022 .

[32]  D. Dunger,et al.  The effects of recombinant human IGF-I administration on concentrations of acid labile subunit, IGF binding protein-3, IGF-I, IGF-II and proteolysis of IGF binding protein-3 in adolescents with insulin-dependent diabetes mellitus. , 1998, The Journal of endocrinology.

[33]  D. Le Roith,et al.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. , 1997 .

[34]  Tim J. Cole,et al.  Measurement of diet in a large national survey: comparison of computerized and manual coding of records in household measures , 1995 .

[35]  S B Roberts,et al.  Exercise training and nutritional supplementation for physical frailty in very elderly people. , 1994, The New England journal of medicine.

[36]  P. Elwood,et al.  Diet and incident ischaemic heart disease: the Caerphilly Study , 1993, British Journal of Nutrition.

[37]  M. Blackman,et al.  Human growth hormone and human aging. , 1993, Endocrine reviews.

[38]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[39]  Diane Podsiadlo,et al.  The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons , 1991, Journal of the American Geriatrics Society.

[40]  T M Hayes,et al.  Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies. , 1988, Journal of epidemiology and community health.

[41]  G. Rose,et al.  Self-administration of a questionnaire on chest pain and intermittent claudication. , 1977, British journal of preventive & social medicine.

[42]  F. Clavel-Chapelon,et al.  Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women , 2007, European Journal of Clinical Nutrition.

[43]  L. Ferrucci,et al.  Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[44]  T. Peters,et al.  Do height-related variations in insulin-like growth factors underlie the associations of stature with adult chronic disease? , 2004, The Journal of clinical endocrinology and metabolism.

[45]  T. Cole,et al.  Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data. , 2002, Statistics in medicine.

[46]  W. Willett,et al.  Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  R. Frost,et al.  IGFBP-3. Functional and structural implications in aging and wasting syndromes. , 1997, Endocrine.

[48]  V. Mitev,et al.  [Insulin-like growth factors]. , 1990, Eksperimentalna meditsina i morfologiia.

[49]  Wolfgang Babisch,et al.  Traffic noise, work noise and cardiovascular risk factors : the Caerphilly and Speedwell collaborative heart disease studies , 1990 .